WORK Medical Technology Group LTD

$1.2 ▼ -4.17%
2026-04-21 10:17:01

Explore WORK Medical Technology Group LTD stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$1.6 M
Current Price
$1.2
52W High / Low
$10,800 / $1.05
Stock P/E
Book Value
$17.7
Dividend Yield
ROCE
-4.23%
ROE
-6.45%
Face Value
EPS
$-400
Exp Qtr EPS
Sector
Healthcare
Industry
Medical Devices
Employees
238
Beta
Debt / Equity
30.32
Current Ratio
1.71
Quick Ratio
1.5
Forward P/E
Price / Sales
0.17
Enterprise Value
$6.74 M
EV / EBITDA
-4.29
EV / Revenue
0.68
Rating
None
Target Price
EPS Forecast (FY)

Pros

  • Balance sheet leverage appears manageable.
  • Short-term liquidity looks comfortable.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Operating margin is thin.
  • Net margin is relatively low.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Establishment Labs Holdings Inc. $66.93 $1.96 B -14.18% -1.33% $83.31 / $28.67 $0.8
2. Inspire Medical Systems, Inc. $56.97 11.28 $1.64 B 6.28% 19.77% $163.35 / $48.3 $27.33
3. Zimmer Biomet Holdings, Inc. $94.32 26.61 $18.29 B 1.04% 6.61% 5.6% $108.29 / $84.59 $64.95
4. Tactile Systems Technology, Inc. $25.52 30.42 $580.59 M 12.57% 8.77% $37.77 / $8.61 $9.76
5. Profound Medical Corp. $7.15 $331 M -57.78% -67.11% $12.4 / $5.23 $1.83
6. SS Innovations International, Inc. $4.85 $971.12 M -17.08% -46.94% $22.42 / $3.02 $0.2
7. Picard Medical, Inc. $0.9 $69.69 M -344.07% 270.74% $13.68 / $0.9 $0.05

Quarterly Results

Figures shown in M / B

Sales
Operating Profit
Net Profit
EPS in Rs

Profit & Loss

Figures shown in M / B

2025202420232022
Sales9.85 M11.51 M13.57 M19.71 M
Operating Profit-0.9 M-3.7 M0.49 M1.82 M
Net Profit-1.07 M-3.49 M0.11 M0.87 M
EPS in Rs-0.88-2.860.090.71

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets33.16 M36.25 M29.96 M25.54 M
Total Liabilities11.99 M20.18 M18.97 M14.35 M
Equity18.34 M13.19 M9.88 M10 M
Current Assets20.46 M20.83 M22.15 M16.61 M
Current Liabilities11.97 M20.18 M18.92 M14.26 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF6.24 M-2.23 M2.21 M-2.26 M
Investing CF-7.61 M-9.06 M-0.58 M-1.35 M
Financing CF-0.9 M15.66 M-0.73 M3.57 M
Free CF4.91 M-11.49 M1.63 M-4.27 M
Capex-1.33 M-9.26 M-0.58 M-2.01 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

2024202320222021
Revenue Growth %-15.18%-31.18%
Earnings Growth %-3217.31%-87.05%
Profit Margin %-30.35%0.83%4.39%
Operating Margin %-32.14%3.59%9.26%
Gross Margin %24.93%30.54%22.42%
EBITDA Margin %-14.75%15.53%23.97%

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

No dividend history available.

Stock Splits

DateSplit
2025-12-291:0.01
2025-10-211:0.01

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
UBS Group AG Institutional 0 M $0 M 0% 2025-12-31
North Star Investment Management Corp Institutional 0 M $0 M 0% 2025-12-31
Bank of America Corporation Institutional 0 M $0 M 2025-12-31